Indacaterol Acetate (Micronized) CAS Number 1000160-96-2

Indacaterol acetate is a medication used to treat breathing difficulties associated with chronic obstructive pulmonary disease (COPD). It is a long-acting bronchodilator, meaning it relaxes the muscles in the airways to improve airflow to the lungs and ease symptoms like coughing, wheezing, and shortness of breath. Indacaterol acetate is typically administered via inhalation using a dry powder inhaler.

Mechanism of action:
Indacaterol, the active component, is a beta2-adrenergic agonist that works by relaxing the muscles in the bronchial tubes, widening the airways and allowing for easier breathing.

COPD Treatment:
Indacaterol acetate is specifically approved for the long-term maintenance treatment of COPD.

Dry powder inhaler:
Indacaterol acetate is delivered as a dry powder formulation for inhalation, typically through a device like the Neohaler or Breezhaler.

Combination therapy:
Indacaterol acetate is also available in combination with other medications, such as mometasone furoate (an inhaled corticosteroid), to further manage COPD symptoms and reduce exacerbations.

Chemical Formula
C26H32N2O5